Search Tag: cell-based therapies

ICU Management

2024 13 Feb

  Cell-based therapies, particularly mesenchymal stromal cells (MSCs), hold significant promise for treating acute respiratory distress syndrome (ARDS). MSCs exhibit therapeutic effects such as reducing inflammation, improving lung function, and promoting tissue repair. These cells can be sourced from different tissues, affecting their ease of harvest...Read more

Executive Health Management

2022 20 Sep

Lykan Bioscience, an innovative contract development and manufacturing organization (CDMO) focused on cell-based therapies welcomes  Barbara Ressler, Ph.D.   as Vice President, Manufacturing Process Sciences. Dr. Ressler will join the executive leadership team and will be responsible for Lykan’s analytical development, process development and manufacturing...Read more